Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Correlation of High-Grade Osteosarcoma Response to Chemotherapy with Enhanced Tissue Immunological Response: Analysis of CD95R, IFN-γ, Catalase, Hsp70, and VEGF

    High-grade osteosarcoma, a primary malignant bone tumour, is experiencing a global increase in reported incidence with varied prevalence. Despite advances in management, which include surgery and neoadjuvant c...

    Sjahjenny Mustokoweni, Ferdiansyah Mahyudin, Rosy Setiawati in Virchows Archiv (2024)

  2. No Access

    Article

    Immunological factors linked to geographical variation in vaccine responses

    Vaccination is one of medicine’s greatest achievements; however, its full potential is hampered by considerable variation in efficacy across populations and geographical regions. For example, attenuated malari...

    Marloes M. A. R. van Dorst, Jeremia J. Pyuza in Nature Reviews Immunology (2024)

  3. Article

    Open Access

    Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

    The phase III clinical study of adjuvant liposomal muramyl tripeptide (MTP-PE) in resected high-grade osteosarcoma (OS) documented positive results that have been translated into regulatory approval, supportin...

    David J. Barnes, Peter Dutton, Øyvind Bruland, Hans Gelderblom, Ade Faleti in BMC Cancer (2022)

  4. Article

    Open Access

    Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier

    In this study, the effect of heterozygous germline mutations in the heparan sulfate (HS) glycosaminoglycan chain co-polymerases EXT1 and EXT2 on glomerular barrier function and the endothelial glycocalyx in hu...

    Ramzi Khalil, Margien G. S. Boels in Molecular Genetics and Genomics (2022)

  5. Article

    Open Access

    The adapter protein Myd88 plays an important role in limiting mycobacterial growth in a zebrafish model for tuberculosis

    Tuberculosis (TB) is the most prevalent bacterial infectious disease in the world, caused by the pathogen Mycobacterium tuberculosis (Mtb). In this study, we have used Mycobacterium marinum (Mm) infection in zebr...

    Rohola Hosseini, Gerda E. M. Lamers, Erik Bos, Pancras C. W. Hogendoorn in Virchows Archiv (2021)

  6. Article

    Open Access

    Co-existence of lung carcinoma metastasis and enchondroma in the femur of a patient with Ollier disease

    Tumour-to-tumour metastasis is very unusual and has been defined as a tumour metastasis into another histologically different tumour. It is extremely rare in bone. We report a case of lung squamous cell carcin...

    Xudong Wang, **aohui Zhang, Wenling Pan, Yuedong Han, Yanwei Li in Virchows Archiv (2021)

  7. Article

    Open Access

    Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma

    Recently, specific driver mutations were identified in chondroblastoma, giant cell tumour of bone and central cartilaginous tumours (specifically enchondroma and central chondrosarcoma), sharing the ability to...

    Sanne Venneker, Karoly Szuhai, Pancras C. W. Hogendoorn in Virchows Archiv (2020)

  8. Article

    Open Access

    A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup

    There is lack of consensus on the prognostic value of received high dose intensity in osteosarcoma survivorship. Many studies have not shown a clear survival benefit when dose intensity is increased. The aim o...

    Carlo Lancia, Jakob K. Anninga, Matthew R. Sydes in Cancer Chemotherapy and Pharmacology (2019)

  9. Article

    Open Access

    New indicators and indexes for benchmarking university–industry–government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project

    While the European Union is striving to become the ‘Innovation Union’, there remains a lack of quantifiable indicators to compare and benchmark regional innovation clusters. To address this issue, a HealthTIES...

    Laurel D. Edmunds, Silvia Gluderer, Pavel V. Ovseiko in Health Research Policy and Systems (2019)

  10. No Access

    Article

    Book Review—Diagnostic pathology: bone, 2nd edition

    Pancras C. W. Hogendoorn in Virchows Archiv (2018)

  11. Article

    Open Access

    Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma

    Ewing sarcoma is an aggressive, highly metastatic primary bone and soft tissue tumor most frequently occurring in the bone of young adolescents. Patients, especially those diagnosed with a metastatic disease, ...

    Laurens G. L. Sand, Tessa Buckle, Fijs W. B. van Leeuwen, Willem E. Corver in BMC Cancer (2017)

  12. Article

    Open Access

    High prevalence of autoimmune disease in the rare inflammatory bone disorder sternocostoclavicular hyperostosis: survey of a Dutch cohort

    Sternocostoclavicular hyperostosis (SCCH; ORPHA178311) is a rare inflammatory disorder of the axial skeleton, the precise pathophysiology of which remains to be established. We addressed the potential associat...

    Pieter A. Valkema, Clare H. Luymes in Orphanet Journal of Rare Diseases (2017)

  13. Article

    Open Access

    Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy

    Ewing sarcoma is an aggressive neoplasm predominantly occurring in adolescents and has a poor prognosis when metastasized. For patients with metastatic disease in particular, immunotherapy has been proposed as...

    Laurens G. L. Sand, Dagmar Berghuis, Karoly Szuhai in Cancer Immunology, Immunotherapy (2016)

  14. No Access

    Chapter

    Automation of Technology for Cancer Research

    Zebrafish embryos can be obtained for research purposes in large numbers at low cost and embryos develop externally in limited space, making them highly suitable for high-throughput cancer studies and drug scr...

    Wietske van der Ent, Wouter J. Veneman, Arwin Groenewoud in Cancer and Zebrafish (2016)

  15. Article

    Open Access

    Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture

    In vitro expanded mesenchymal stromal cells (MSCs) are increasingly used as experimental cellular therapy. However, there have been concerns regarding the safety of their use, particularly with regard to possi...

    Emilie P Buddingh, S Eriaty N Ruslan in Clinical Sarcoma Research (2015)

  16. No Access

    Article

    GRM1 is upregulated through gene fusion and promoter swap** in chondromyxoid fibroma

    Karolin Nord and colleagues report that GRM1 recombines with multiple genes in promoter swap** and gene fusion events in 90% of the chondromyxoid fibroma cases analyzed, resulting in GRM1 overexpression. These ...

    Karolin H Nord, Henrik Lilljebjörn, Francesco Vezzi, Jenny Nilsson in Nature Genetics (2014)

  17. Article

    Open Access

    Possible effects of EXT2 on mesenchymal differentiation - lessons from the zebrafish

    Mutations in the EXT genes disrupt polymerisation of heparan sulphates (HS) and lead to the development of osteochondroma, an isolated/sporadic- or a multifocal/hereditary cartilaginous bone tumour. Zebrafish (Da...

    Malgorzata I Wiweger, Carlos E de Andrea in Orphanet Journal of Rare Diseases (2014)

  18. No Access

    Article

    The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone

    Primary bone lymphoma (PBL) comprises 5 % of all extranodal non-Hodgkin's lymphomas (NHLs). Diffuse large B-cell lymphoma (DLBCL) accounts for the majority of cases, which is the most heterogeneous group of ly...

    Hajnalka Rajnai, Fenna H. Heyning, Lianne Koens, Anna Sebestyén in Virchows Archiv (2014)

  19. No Access

    Article

    Frequent truncating mutations of STAG2 in bladder cancer

    Todd Waldman and colleagues screened 2,214 tumors for loss of STAG2 expression using immunohistochemistry. They followed up by sequencing STAG2 in 111 urothelial carcinomas and found mutations in 23 of the cases,...

    David A Solomon, Jung-Sik Kim, Jolanta Bondaruk, Shahrokh F Shariat in Nature Genetics (2013)

  20. Article

    Open Access

    Mesenchymal stem cell transformation and sarcoma genesis

    MSCs are hypothesized to potentially give rise to sarcomas after transformation and therefore serve as a good model to study sarcomagenesis. Both spontaneous and induced transformation of MSCs have been report...

    Wei **ao, Alexander B Mohseny, Pancras C W Hogendoorn in Clinical Sarcoma Research (2013)

previous disabled Page of 3